InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Discover the detailed record of transactions filed by Semba Charles Pauling. Officer active across 1 company, notably DiaMedica Therapeutics Inc.. In total, 5 disclosures have been logged. Split: 1 buy · 0 sell. Total volume traded: €46k. History available since 3 January 2023. The latest transaction was disclosed on 2 January 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Semba Charles Pauling is a declarant and a director of DiaMedica Therapeutics Inc. (XNAS). Across the 4 filings on record, the recent filings cover the period from 2023-01-03 to 2025-01-03, with EUR 45622 of buys and EUR 0 of sells, and the modal transaction nature is Attribution.